Skip to content
Newsroom

$4M Funding Furthers Belluscura’s U.S. Expansion Goals

Sallyport Commercial Finance is delighted to announce a $4,000,000 funding facility for Belluscura, a trailblazing medical device company focused on developing innovative oxygen enrichment technology. The funding, comprising accounts receivable and cash flow loans, will empower Belluscura to expand its operations into the U.S. market, supporting the production and distribution of their groundbreaking oxygen treatment devices.

Belluscura is on a mission to improve health outcomes for patients with Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Their enriched oxygen treatment platforms are designed to enhance patient care while delivering favorable economic outcomes for healthcare providers and insurance companies. By innovating rapidly and navigating regulatory pathways efficiently, Belluscura aims to reduce treatment costs, increase available options and deliver value to patients.

The strategic move to secure funding from Sallyport comes at a critical time for Belluscura, as they prepare for the formal launch of their device in 2025 following a successful soft launch. This financial boost will enable the company to scale production and capitalize on growing demand in the business-to-business market.

Nick Hart, President of Sallyport Commercial Finance, shared his excitement about the partnership:

“Sallyport is proud to fuel innovation and growth for companies like Belluscura. This funding underscores our commitment to empowering businesses to deliver life-enhancing solutions, such as their groundbreaking oxygen devices, to a global market.”

This partnership highlights Sallyport’s unique ability to support UK-owned subsidiaries operating in North America, where other lenders often hesitate. By working closely with Cadence Advisory, Sallyport was able to provide the financial resources Belluscura needs to achieve its ambitious goals.

Belluscura’s dedication to improving healthcare outcomes and reducing treatment costs aligns perfectly with Sallyport’s mission to empower businesses to thrive and achieve a meaningful impact in their industries.

For more information on how Sallyport can support your business growth, reach out to us today!

Posted in
  • News

$1M Funding Fuels Agri-Business Growth Across Borders

May 30, 2025

Sallyport is pleased to announce a new partnership with a Canadian agriculture business, providing a $1,000,000 Accounts Receivable facility to…

Read More

Fueling EdTech Growth with $5.5M in Tailored Financing

May 22, 2025

Sallyport is excited to support a forward-thinking education technology company with a $5.5M combined Asset-Based Lending facility, including Accounts Receivable…

Read More
  • Articles

Succession Planning – or Lack Thereof = Risk!

Succession Planning – or Lack Thereof = Risk! By Emma Hart Risk mitigation in our industry is, quite rightly, primarily…

Read More
feature-image-for-interest-rate-risk-blog-man-building-blocks-with-percentages-on-them

Financing Business Through Interest Rate Risk

Just a few short months back business owners were earnestly trying to come back from Omicron and wondering whether they…

Read More
  • Videos

AG Machining Client Testimonial

AG Machining Client Testimonial   

View Now

American Business Women’s Day

Sallyport Commercial Finance Celebrates American Business Women’s Day  

View Now
Scroll To Top